(AFL) Aflac Incorporated Company Overview

What does Aflac Incorporated do?

Aflac Incorporated is a supplemental health and life insurer listed on the New York Stock Exchange under AFL. Its core idea is simple: when a policyholder is sick, hurt, or facing a covered medical event, Aflac products can pay cash benefits that help cover expenses major medical insurance may not fully address. The company describes this role on its official about Aflac page, and that positioning explains why the business is closer to a cash-benefit protection model than to a traditional managed-care insurer.

Why the Japan-and-U.S. footprint matters

Aflac is unusual because Japan is the larger earnings engine even though the parent company is U.S.-based. The latest FY2025 Form 10-K says Aflac Japan is the principal contributor to consolidated earnings, while Aflac U.S. provides accident, cancer, critical illness, hospital indemnity, disability, dental, vision, and life products in the American workplace and individual markets. That mix creates a dual analytical lens: Japan drives scale, margin, and currency exposure; the U.S. business drives workplace distribution, group products, and domestic growth.

What products does it sell?

The customer proposition is not hospital ownership or broad medical-provider networks. It is supplemental protection: cash benefits around accident, illness, cancer, critical illness, hospital stay, short-term disability, dental, vision, and life needs. Aflac’s official product pages show why this model is attractive for employers and households: the benefit is understandable, can be sold in small policies, and can be attached to workplace enrollment or affinity channels.

How does Aflac make money?

Aflac makes money from premiums and investment income, then protects profitability by pricing policies, managing claims, retaining policyholders, controlling expenses, and investing the float-like asset base. Unlike a software company, revenue growth is not the only useful signal. For an insurer, the key economic question is whether premiums and investment income exceed benefits, claims, acquisition costs, operating expenses, interest expense, taxes, and capital needs across the cycle.

Which segment matters most?

Aflac Japan matters most to consolidated pretax adjusted earnings. In FY2025, Japan generated about $3.44 billion of pretax adjusted earnings, compared with $1.42 billion from Aflac U.S. and $101 million from Corporate and other. The business therefore does not analyze like a simple U.S. benefits company. Japan product demand, Japan distribution alliances, yen-dollar translation, Japanese regulation, and Japanese cybersecurity controls can all move the consolidated story.

What creates margin in this model?

The strongest margin levers are product pricing, claims experience, persistency, investment yield, and expense discipline. In FY2025, Aflac Japan’s pretax adjusted margin was materially higher than Aflac U.S., while the U.S. segment benefited from annualized premiums in force rising to $6.7 billion. This is the central strategic trade-off: Japan provides a large, established earnings base; the U.S. business offers growth through workplace and group distribution, but with lower pretax margin.

What does Aflac's latest quarter show?

The latest official reporting package is the first quarter of 2026. Aflac’s Q1 2026 earnings release shows a sharp increase in GAAP net earnings, steady adjusted earnings, and a large capital return. The headline gap between GAAP and adjusted results matters because the prior-year quarter included large net investment losses, while Q1 2026 included net investment gains.

How should the Q1 2026 numbers be read?

The quarter was not a simple organic growth story. Total revenues rose 27.9% to $4.346 billion, while adjusted earnings declined slightly to $901 million and adjusted EPS rose 5.4% to $1.75. The EPS improvement despite lower adjusted earnings reflects a smaller share count after repurchases. Diluted weighted-average shares fell from 546.9 million in Q1 2025 to 514.8 million in Q1 2026, a decline of roughly 5.9%.

Japan versus U.S. in the latest period

Segment details reinforce the company’s two-speed profile. Aflac Japan posted Q1 2026 pretax adjusted earnings of $759 million on $2.172 billion of total adjusted revenues, with premium persistency of 92.8% and a pretax margin of 35.0%. Aflac U.S. generated $363 million of pretax adjusted earnings on $1.779 billion of total adjusted revenues, with premium persistency of 79.3% and a pretax margin of 20.4%.

Why do Japan distribution, yen translation, and medical products define Aflac's model?

Aflac Japan is not just a geographic segment; it is the strategic center of the company. The segment sells cancer, medical, and life products through a dense network of independent agencies, corporate alliances, banks, and postal channels. That distribution structure is hard for a new entrant to replicate quickly, but it also creates partner dependence and regulatory complexity.

Why is persistency a key KPI?

Premium persistency measures how much of the policy base remains in force. For Aflac Japan, Q1 2026 persistency was 92.8%, compared with 79.3% for Aflac U.S. Higher persistency can improve lifetime policy economics because acquisition costs are recovered over a longer premium stream. In a DCF or insurance earnings model, this affects revenue durability, claims expectations, expense leverage, and the quality of future cash flows.

How does currency enter the analysis?

The functional currency of Aflac Japan is the yen, but the parent reports in U.S. dollars. In Q1 2026, the average yen-dollar exchange rate was 156.87 versus 152.40 a year earlier, a 2.8% weaker yen that reduced adjusted EPS by $0.02. In FY2025, the weighted-average rate used for Japan segment comparisons was 149.32. For valuation, that means consolidated dollar earnings can move even when yen-denominated operating trends are healthier than reported dollar figures suggest.

What strategic turning points shaped Aflac today?

Aflac’s history matters because the company’s present strengths are cumulative: a focused supplemental-insurance brand, deep Japan distribution, recurring premium income, and a long-standing shareholder-return pattern. The official company history begins with the Amos brothers in 1955, but the most relevant strategic developments are the channel and balance-sheet decisions that still shape results.

1. 1955
   John, Paul, and Bill Amos founded the company with a policyholder-focused protection idea. That origin still explains the simple cash-benefit proposition.
2. 2001
   The Dai-ichi Life alliance launched in Japan, later giving Aflac access to roughly 37,000 representatives for cancer products at FY2025 year-end.
3. 2008-2013
   The Japan Post alliance began in 2008 and was strengthened in 2013, extending reach into postal outlets and making Japan Post a strategic commercial partner.
4. 2013
   The Daido Life alliance launched, adding another affiliated corporate channel and reinforcing Aflac Japan’s multi-partner distribution system.
5. 2019
   Japan Post-linked J&A Alliance Holdings became a major holder through a trust structure, tying commercial partnership and governance analysis together.
6. 2025
   The company absorbed cybersecurity-related costs and continued capital returns, highlighting that operational resilience and shareholder distributions now sit side by side.
7. 2026
   Japan product sales momentum from Anshin Palette, Miraito, and Tsumitasu helped Q1 2026 Japan sales rise 25.5% in yen terms.

How does the alliance model compound scale?

The strategic lesson is that Aflac’s moat is not only brand awareness. It is also channel architecture. Independent agencies, affiliated life insurers, banks, and postal outlets create multiple paths to the same household financial-protection need. This reduces reliance on a single distribution route, although it does not eliminate partner concentration risk. The Japan Post relationship, for example, was associated with policies representing about 6.7% of Aflac Japan earned premium and 3.3% of consolidated earned premium in FY2025.

What gives Aflac a competitive advantage?

Aflac competes in insurance markets where products can look similar, regulation is heavy, and customer acquisition can be expensive. Its advantage therefore comes from a combination of brand trust, policyholder focus, distribution reach, claims experience, investment scale, and product familiarity in cancer and medical protection. The company’s filings emphasize that deregulation made Japan’s third-sector market more competitive after 2001, so the moat has to be renewed through channel productivity and product relevance rather than assumed from history.

Which competitors pressure the business?

The competitive set differs by market. In Japan, Aflac faces life and health insurers that sell cancer, medical, and stand-alone third-sector products after deregulation widened competition. In the United States, the company competes with voluntary benefits providers, group insurers, brokers, and carriers that sell accident, critical illness, disability, dental, vision, and life products through employers. The competitive question is less “who has one similar product?” and more “who controls the employer, bank, postal, agency, or broker relationship at enrollment?”

How financially strong is Aflac?

Aflac’s financial strength is best judged through capital, investment assets, policy liabilities, cash flow, and shareholder returns. At March 31, 2026, the company reported total assets of $116.280 billion, total investments and cash of $103.192 billion, policy liabilities of $66.782 billion, notes payable and lease obligations of $7.908 billion, and shareholders’ equity of $30.0 billion. For an insurer, the balance sheet is the business model, not just a financing footnote.

What did FY2025 show about cash flow and capital allocation?

FY2025 operating cash flow was $2.555 billion. The company used $3.530 billion for treasury stock purchases and paid $1.198 billion in dividends. That combination exceeded operating cash flow for the year, so the analysis must consider the broader balance sheet, investing cash flows, debt activity, and capital adequacy rather than treating free cash flow as the only source of distributions.

How do profitability and investment yield interact?

Aflac’s earnings are shaped by underwriting-style margins and portfolio returns. In FY2025, Aflac Japan’s return on average invested assets was 3.22% and its portfolio book yield was 3.26%, while Aflac U.S. had a return on average invested assets of 4.94% and a portfolio book yield of 5.47%. Higher U.S. yields can help earnings, but they do not by themselves overcome Japan’s larger segment scale and higher pretax margin.

Who owns Aflac stock, and why does voting structure matter?

Aflac has one publicly traded common-stock class, but it uses time-phased voting. The 2026 proxy statement explains that each share receives one vote until it has been held by the same beneficial owner for more than 48 months; after that, it receives ten votes. This gives long-term holders more influence than short-term holders and makes economic ownership different from voting power.

How does time-phased voting change investor interpretation?

At the 2026 record date, 515.2 million shares were outstanding. About 429.7 million shares carried one vote each, while 85.5 million long-term shares carried ten votes each, for roughly 1.285 billion assumed votes. That means about 16.6% of shares represented roughly 66.6% of assumed voting power. This structure rewards long-term holders and can stabilize governance, but it also means voting analysis cannot be inferred from share count alone.

What risks and opportunities should researchers monitor?

Aflac’s opportunity set is not hard to identify: Japan medical and cancer product renewal, U.S. group and broker growth, higher investment yields, expense discipline, and buybacks can all support per-share results. The risks are equally specific: yen translation, claims assumptions, Japan regulation, partner dependence, cybersecurity, investment losses, and the possibility that capital returns exceed sustainable operating cash flow in a tougher environment.

What risk appears most material in the latest filings?

Cybersecurity deserves current attention. Aflac filed a June 30, 2026 Form 8-K stating that Aflac Japan discovered unauthorized third-party access to certain Japan systems between June 15 and June 25, 2026. The company said the incident was limited to Japan, that U.S. systems were not accessed, and that the full scope and ultimate impact were not yet known. For investors and students, this is a useful example of how operational risk can become regulatory, reputational, legal, and financial risk in a trust-based insurance model.

Which KPIs should students and investors watch?

Why does Aflac matter for valuation and DCF analysis?

For valuation, Aflac is a case study in separating operating economics from accounting noise. GAAP results can move sharply with investment gains or losses, yen translation, and accumulated other comprehensive income. A useful model therefore starts with segment premiums, claims, expenses, investment income, capital needs, and share count rather than a single revenue-growth assumption.

What is the key takeaway from Aflac analysis?

Aflac is important because it combines a recognizable supplemental-insurance brand, a Japan-heavy earnings base, a U.S. voluntary-benefits platform, large investment portfolios, and an aggressive shareholder-return culture. The company’s strongest analytical support comes from Japan scale, high Japan persistency, segment profitability, investment income, and long-term distribution alliances. The pressure points are equally concrete: yen translation, cyber events, claims assumptions, partner reliance, investment volatility, and the need to balance buybacks with insurer capital strength.